Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck m-M-R II — Worldwide reported growth YoY (%) (%)
Form 10-Q / 10-K MD&A Pediatric Vaccines Disclosure
Latest, FY2025
3.0%
Period ended Dec 31, 2025
Change on a year earlier
-5.0 pts
8.0% in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | M-M-R II — Worldwide reported growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.0% | -5.0 pts | Form 10-K (mrk-20251231.htm, filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 8.0% | +3.0 pts | Form 10-K (mrk-20251231.htm, filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 5.0% | 0.0 pts | Form 10-K (mrk-20241231.htm, filed 2025-02-25) ↗ |
| FY2022 | Dec 31, 2022 | 5.0% | +2.0 pts | Form 10-K (mrk-20231231.htm, filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 3.0% | +34.0 pts | Form 10-K (mrk-20221231.htm, filed 2023-02-24) ↗ |
| FY2020 | Dec 31, 2020 | -31.0% | -59.0 pts | Form 10-K (mrk-20211231.htm, filed 2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 28.0% | +15.0 pts | Form 10-K (mrk-20201231.htm, filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 13.0% | – | Form 10-K (mrk1231201910k.htm, filed 2020-02-26) ↗ |
Cite this data
StockData. (2026). Merck M-M-R II — Worldwide reported growth YoY (%) (%), annual FY2018–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev_mmr_ii_nom_yoy
See every metric in the Merck KPI table. Data updated Oct 26, 2026.